TL;DR
Get health and wellness essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A MedpageToday endocrinology roundup published October 6, 2026, covered three developments: wearable tracking of menopause-related information, increased GLP-1 prescribing among bariatric-surgery-eligible adolescents, and a meta-analysis linking iatrogenic menopause with higher cardiovascular and mortality risks. The cited reports do not establish what wearables can reliably measure or explain why most eligible teens received neither medication nor surgery.
A MedpageToday endocrinology roundup published October 6, 2026, highlighted questions about tracking menopause with wearables, a rise in GLP-1 prescriptions for bariatric-surgery-eligible teens, and a meta-analysis associating iatrogenic menopause with higher risks of cardiovascular outcomes and death. The items point to developments in care and research, but the roundup provides limited study details and does not establish that wearable data can diagnose menopause or that the reported associations prove cause and effect.
The roundup cited a New York Times report asking what menopause-related information devices such as Apple Watches can track. The supplied summary gives no findings about particular measures, device accuracy, or whether the data can help clinicians make a diagnosis. It therefore raises a reporting question rather than confirming a specific wearable capability.
It also cited a JAMA Pediatrics study reporting that GLP-1 medication prescribing increased between 2017 and 2025 among adolescents eligible for bariatric surgery. Despite that increase, nine out of 10 eligible adolescents received neither GLP-1 medication nor bariatric surgery, according to the summary. The source does not give the number of adolescents studied, prescribing rates by year, or reasons for the treatment gap.
A separate meta-analysis of 36 studies, published in JAMA Network Open, found that iatrogenic menopause was associated with significantly higher risks of stroke, coronary heart disease, a composite of cardiovascular events, and all-cause mortality. Iatrogenic menopause refers to menopause brought on by medical intervention. The summary does not specify which interventions were included, the size of the reported risks, or how the studies handled differences among patients.
Gaps in Menopause and Teen Care
Together, the items concern decisions patients and clinicians may face: whether consumer devices provide useful information about menopause, how adolescents who meet criteria for obesity treatment access care, and what longer-term health risks may follow medically induced menopause. The reported findings do not supply enough detail to guide individual decisions, but they identify areas where clinicians, researchers and health systems may need better evidence.
The teen prescribing figures are particularly relevant to access: a rise over time did not mean that most eligible adolescents received either of the two treatments counted in the report. The available summary does not say whether that reflects patient choice, clinical judgment, cost, availability, or other factors. Likewise, the menopause meta-analysis signals an association that may matter in evaluating care, but it does not establish that iatrogenic menopause itself caused the outcomes.
menopause tracking wearable device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Three Developments in Endocrinology
The three topics appeared alongside other items in a brief endocrinology news roundup, rather than in a single study or coordinated policy announcement. The roundup also said the World Health Organization was due to launch two guidelines on the integrated management of obesity in children and adolescents on Wednesday. It did not identify the calendar date for that Wednesday or provide the guidelines’ recommendations.
The cited research and coverage came from separate outlets and journals: the New York Times on wearable tracking, JAMA Pediatrics on teen prescribing, and JAMA Network Open on iatrogenic menopause outcomes. Because the roundup condenses these sources, it does not provide enough information to compare methods, populations, or the strength of evidence across the three subjects.
As an affiliate, we earn on qualifying purchases.
Evidence and Access Questions Remain
The roundup does not identify which menopause-related signals wearables may capture, how accurate they are, or whether they have been validated for clinical use. Tracking a bodily measure is not the same as diagnosing menopause, and the supplied material does not support claims about either capability.
For the teen study, the reasons that 90% of eligible adolescents went without either treatment remain unknown from the summary. It also does not clarify whether the study counted prescriptions that were filled or treatment actually received. For the meta-analysis, absolute risk figures, patient characteristics, intervention types and study limitations are not provided. The reported associations should not be read as proof that iatrogenic menopause causes stroke, heart disease or death.
As an affiliate, we earn on qualifying purchases.
Full Studies and Guidelines Ahead
Readers seeking details will need the full articles and study reports, including the wearable measures assessed, the teen cohort and treatment definitions, and the meta-analysis methods and risk estimates. Those details are not included in the roundup summary provided here.
The roundup said the World Health Organization was scheduled to release two guidelines on managing obesity in children and adolescents on Wednesday. Their publication date and recommendations remain unspecified in the source material. Any implications for teen treatment will depend on what the guidelines say and how clinicians and health systems apply them.
As an affiliate, we earn on qualifying purchases.
Key Questions
What can a wearable track about menopause?
The cited roundup points to a New York Times report posing that question, but it does not list specific signals or establish device accuracy. It does not show that a wearable can diagnose menopause.
Did GLP-1 prescribing increase among eligible teens?
Yes. The roundup says a JAMA Pediatrics study found prescribing rose from 2017 to 2025 among adolescents eligible for bariatric surgery. It also reports that nine in 10 received neither GLP-1 medication nor surgery.
Why did most eligible adolescents receive neither treatment?
The supplied summary does not say. It gives no breakdown of reasons such as access, cost, clinical decisions or patient preferences.
What health outcomes were associated with iatrogenic menopause?
A meta-analysis of 36 studies reported associations with higher risks of stroke, coronary heart disease, composite cardiovascular events and all-cause mortality. The summary does not provide absolute risks or establish causation.
When will the WHO obesity guidelines appear?
The roundup said two WHO guidelines on integrated obesity management in children and adolescents would launch Wednesday, but it did not give the calendar date or recommendations.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
